Lynn A. Tetrault - 18 Jun 2025 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Lynn A. Tetrault
Issuer symbol
RYTM
Transactions as of
18 Jun 2025
Net transactions value
$0
Form type
4
Filing time
23 Jun 2025, 16:48:06 UTC
Previous filing
03 Jun 2025
Next filing
26 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
TETRAULT LYNN A. Director 222 BERKELEY STREET, 12TH FLOOR, BOSTON /s/ Stephen Vander Stoep, attorney-in-fact for Lynn A. Tetrault 23 Jun 2025 0001645512

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +4,000 +133% 7,000 18 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -4,000 -100% $0.000000 0 18 Jun 2025 Common Stock 4,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date.